Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in Ischemic Cardiomyopathy
NCT01345188Phase 4Completed
- Sponsor
- Midwest Cardiovascular Research Foundation
- Start
- Apr 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in ischemic cardiomyopathy (ICM), sponsored by Midwest Cardiovascular Research Foundation. Started Apr 2011; status: completed.
02
Drugs
ranolazine
03
Conditions
ischemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on NCT01345188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01345188.